Sequenta Garners New Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7b513731-f2ee-4b8b-8c11-a43ca305572d - Date
10/20/2014 - Company Name
Sequenta - Mailing Address
400 East Jamie Court South San Francisco, CA 94080 USA - Company Description
Sequenta is a venture funded biotech company dedicated to the discovery and development of clinical diagnostics based on a revolutionary new platform for understanding immune system status. - Website
http://www.sequentainc.com - Transaction Type
Venture Equity - Transaction Amount
Undisclosed - Transaction Round
Undisclosed - Proceeds Purposes
This financing, in addition to funding secured from several other strategic investors, will support incorporation of the ClonoSIGHT minimal residual disease (MRD) test into clinical trials of medicines in development for various hematological malignancies (blood cancers) and development of new clinical diagnostics based on Sequenta’s revolutionary LymphoSIGHT platform. - M&A Terms
- Venture Investor
- Venture Investor
